A Novel Intraoral Technique for Botulinum Toxin Type A Application in the Mentalis Muscle

The mentalis muscle plays a critical role in lower facial balance by stabilizing the lower lip and shaping the chin contour. Botulinum toxin type A (BoNT-A) is commonly used to manage excessive mentalis activity; however, inaccurate injection techniques may lead to functional impairment and undesirable aesthetic outcomes. This technical report describes a novel and innovative intraoral botulinum toxin injection technique targeting the mentalis muscle based on precise anatomical localization of its origin. The proposed method introduces a new intraoral approach designed to improve injection accuracy while minimizing toxin diffusion and preserving lower lip function. A detailed anatomical assessment was performed to define the muscle’s origin, fiber orientation, and relevant surface landmarks, which informed the development of a controlled injection strategy emphasizing precise depth and placement. In clinical application, the technique was performed in three patients, demonstrating consistent modulation of mentalis contraction, improvement in chin surface appearance, and preservation of lower lip function without functional compromise. This new and reproducible technique highlights the importance of anatomical precision in BoNT-A injection planning and provides a practical framework to enhance safety and aesthetic outcomes in treatments of the lower third of the face.

Publication Details

Journal
Cureus
Published
2026-03-24
DOI
https://doi.org/10.7759/cureus.105783
Primary Topic
Botulinum Toxin and Related Neurological Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Novel Intraoral Technique for Botulinum Toxin Type A Application in the Mentalis Muscle

Cureus
Botulinum Toxin and Related Neurological Disorders
article

A Novel Intraoral Technique for Botulinum Toxin Type A Application in the Mentalis Muscle

article en

Abstract

The mentalis muscle plays a critical role in lower facial balance by stabilizing the lower lip and shaping the chin contour. Botulinum toxin type A (BoNT-A) is commonly used to manage excessive mentalis activity; however, inaccurate injection techniques may lead to functional impairment and undesirable aesthetic outcomes. This technical report describes a novel and innovative intraoral botulinum toxin injection technique targeting the mentalis muscle based on precise anatomical localization of its origin. The proposed method introduces a new intraoral approach designed to improve injection accuracy while minimizing toxin diffusion and preserving lower lip function. A detailed anatomical assessment was performed to define the muscle’s origin, fiber orientation, and relevant surface landmarks, which informed the development of a controlled injection strategy emphasizing precise depth and placement. In clinical application, the technique was performed in three patients, demonstrating consistent modulation of mentalis contraction, improvement in chin surface appearance, and preservation of lower lip function without functional compromise. This new and reproducible technique highlights the importance of anatomical precision in BoNT-A injection planning and provides a practical framework to enhance safety and aesthetic outcomes in treatments of the lower third of the face.

Cureus
Sustainable cities and communities
Openalex Percentile: Top 17%
Botulinum Toxin and Related Neurological Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.